In patients with hypertension, an elevated aldosterone–renin ratio (ARR) is used as a screening parameter, followed by confirmatory testing (salt loading, fludrocortisone or captopril administration, which all fail to sufficiently lower aldosterone levels in PA). The gene discussed is REN; the disease is hypertensive disorder.